Bowel disease study points to new therapies for lifelong conditions

May 3, 2018, University of Edinburgh
Micrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0

Treatments for incurable bowel conditions may be a step closer following the discovery of a key molecule associated with disease flare-ups.

Researchers say the finding helps to explain the underlying cause of disorders such as Crohn's disease and .

The discovery could also lead to new tests to help doctors monitor patients' condition and help them to tailor treatments accordingly.

Inflammatory Bowel Disease—or IBD—includes Crohn's Disease and Ulcerative Colitis and affects around 300,000 in the UK. The causes of these disorders are unknown and there is currently no cure.

Scientists at the University of Edinburgh looked for factors that might be associated with disease flare-ups by testing samples from almost 100 people with IBD.

They discovered tiny fragments of DNA in the patients' , which were barely present at all in samples from people who did not have the diseases.

These —called mtDNA—are usually found packaged within energy factories found inside all human cells, called mitochondria.

Mitochondria are tiny cellular structures that descended from an ancient type of bacteria. Because of this, they have DNA similar to modern day bacteria.

In healthy people, when mitochondria become damaged, the mtDNA is recycled and disposed of safely by the body.

These processes do not work properly in people with IBD, however, which enables mtDNA to leak from the affected gut into the blood stream.

The researchers say this tricks the immune system into thinking there is an infection and an inflammatory response ensues. The inflammation causes damage to otherwise healthy tissues and is the cause of the symptoms of IBD.

People with the most severe illness had the highest levels of mtDNA in their blood, the study found. This suggests the molecule could serve as a useful marker to monitor disease progression and help doctors to prescribe appropriate therapies.

The research, published in the journal Inflammatory Bowel Diseases, was funded by Crohn's & Colitis UK and Medical Research Council.

Dr. Gwo-Tzer Ho, who led the study at the University of Edinburgh's MRC Centre for Inflammation Research, said: "We are now investigating how to block these molecules from triggering inflammation, in the hope of developing new therapies to prevent flare-ups and to accelerate patient recovery after an attack."

Explore further: Scientists pinpoint key bowel disease gene

More information: Ray K Boyapati et al, Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD, Inflammatory Bowel Diseases (2018). DOI: 10.1093/ibd/izy095

Related Stories

Scientists pinpoint key bowel disease gene

May 15, 2017
A key gene that helps to explain an underlying cause of incurable bowel disorders such as Crohn's disease has been identified by scientists.

Analysis challenges link between pain medications and inflammatory bowel disease

April 5, 2018
Contrary to generally accepted belief, a recent review and analysis of published studies did not reveal a consistent association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and exacerbation ...

Crohn's and colitis study to probe factors that worsen disease

January 23, 2017
People with Crohn's disease and ulcerative colitis are being invited to take part in a study to better understand the diseases.

Fecal analyses may lead to noninvasive diagnostics for inflammatory bowel disease

February 5, 2016
New research indicates that analyses of vapors from fecal samples can identify volatile metabolites indicative of different types of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Blood test hope for bowel diseases

November 28, 2016
Scientists have identified chemical changes in the DNA of patients with inflammatory bowel diseases that could improve screening for the conditions.

Oxysterols guide gut immune cells and are involved in inflammatory bowel disease

January 16, 2018
Researchers at Karolinska Institutet in Sweden report that cholesterol metabolites cause specific immune cells in the large intestine to move, which lies behind the formation of the immune system's important lymphoid tissue ...

Recommended for you

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

Inflammation can lead to circadian sleep disorders

October 31, 2018
Inflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's disease, has unexpected effects on body clock function and can lead to sleep and shiftwork-type ...

Machine learning tool predicts the potential of peptides as immune activators

October 23, 2018
The immune system keeps T cells under control by regulating precisely when they can respond to a pathogen. For instance, helper T cells only turn "on" if other immune cells, such as antigen-presenting cells (APCs) present ...

A new mechanism in the control of inflammation

October 18, 2018
After infection or tissue injury, the inflammatory immune response attacks the infection and repairs the damaged tissue. However, sometimes excess inflammation can have the opposite effect, increasing injury in a process ...

Sugar, a 'sweet' tool to understand brain injuries

October 15, 2018
Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies.

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.